CARA - Cara Therapeutics Q3 2021 Earnings Preview
Cara Therapeutics (NASDAQ:CARA) is scheduled to announce Q3 earnings results on Monday, November 8th, after market close. The consensus EPS Estimate is -$0.33 and the consensus Revenue Estimate is $11.21M (+20.9% Y/Y). The company posted second-quarter profit that beat Wall Street estimates and provided a cash position update, in August. Seeking Alpha contributor Bret Jensen checked back in on Cara, and highlighted that news flow seems to have picked up around the company recently, earlier this month. Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 1 upward revision and 2 downward. The company's shares have gained more than 16% year to date.
For further details see:
Cara Therapeutics Q3 2021 Earnings Preview